17th Apr 2023 10:17
(Sharecast News) - Medical diagnostics company Omega said on Monday that revenues had contracted in the twelve months ended 31 March.
Read more6th Jan 2023 14:43
(Sharecast News) - Omega Diagnostics announced on Friday that it had received a maiden purchase order for its 'FoodPrint' system from a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory in the United States.
Read more25th Nov 2022 11:33
(Sharecast News) - Omega Diagnostics confirmed the receipt of deferred consideration from the sale of the CD4 business on Friday.
Read more5th Oct 2022 07:38
(Sharecast News) - Omega Diagnostics announced receipt of the draft performance evaluation report for the 'VISITECT CD4' advanced disease rapid test on Wednesday, issued by the World Health Organisation (WHO).
Read more7th Apr 2022 11:06
(Sharecast News) - Medical diagnostics company Omega said on Thursday that full-year revenues were expected to have surged in 2021 but cautioned that ongoing Covid-related income was now anticipated to be minimal.
Read more11th Mar 2022 16:10
(Sharecast News) - Omega Diagnostics announced another disappointment for its Covid-19 tests on Friday, announcing that the UK Health Security Agency said its application for approval of the professional-use 'VISITECT' antigen test under the Coronavirus Test Device Approvals regulations (CTDA) was unsuccessful.
Read more11th Feb 2022 14:21
(Sharecast News) - Medical diagnostics specialist Omega has signed a conditional sale and purchase agreement with Accubio, a wholly-owned subsidiary of Orient Gene, for the sale of its diagnostic test kit manufacturing business and facility in Alva, Scotland.
Read more3rd Feb 2022 15:39
(Sharecast News) - Medical diagnostics specialist Omega has successfully CE-marked its 'Visitect' Covid-19 antigen test for self-test use, it announced on Thursday.
Read more10th Dec 2021 15:17
(Sharecast News) - Omega Diagnostics updated the market on its contract with the UK Department of Health and Social Care (DHSC) to provide manufacturing capacity for Covid-19 lateral flow antigen tests on Friday, indicating it was in disagreement with the government on an alleged repayment requirement.
Read more6th Sep 2021 12:04
(Sharecast News) - Medical diagnostics company Omega announced on Monday that all of the supporting data and documentation relating to its submission for CE-marking for self-test use of its 'Visitect' Covid-19 antigen test had been filed with its European notified body.
Read more8th Jun 2021 09:26
(Sharecast News) - Medical diagnostics company Omega updated the market on regulatory approvals for the 'Visitect' Covid-19 antigen test on Tuesday, confirming that it has started engaging with its European notified body, seeking CE-marking of the test.
Read more7th Jun 2021 10:36
(Sharecast News) - Medical diagnostics company Omega updated the market on its UK government manufacturing contract on Monday, reporting that it remained in regular dialogue with the Department of Health and Social Care (DHSC) to provide manufacturing capacity for Covid-19 lateral flow antigen tests.
Read more30th Apr 2021 13:35
(Sharecast News) - Omega Diagnostics announced the launch of its 'Visitect' Covid-19 antigen test on Friday, which it described as a rapid point-of-care diagnostic test for the detection of active Covid-19 infections.
Read more22nd Mar 2021 12:24
(Sharecast News) - Medical diagnostics company Omega announced on Monday that it has CE-marked Mologic's lateral flow antigen test for Covid-19, to be sold for professional use under its 'Visitect' brand.
Read more15th Mar 2021 11:37
(Sharecast News) - Medical diagnostics company Omega announced on Monday that a public sector contract disclosure had been published in relation to its contract with the Department of Health and Social Care (DHSC) to provide manufacturing capacity for Covid-19 lateral flow antigen testing.
Read more